Proapoptotic and anticarcinogenic activities of leviusculoside G from the starfish Henricia leviuscula and probable molecular mechanism

Natural Product Communications

Volumn 3, Issue 10, 2008, Pages 1575-1580

  Fedorov, Sergey N ^a   Shubina, Larisa K ^a   Kicha, Alla A ^a   Ivanchina, Natalia V ^a   Kwak, Jong Y ^b   Jin, Jun O ^b   Bode, Ann M ^c   Dong, Zigang ^c   Stonik, Valentin A ^a  

^a PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b Dong A University   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

AP 1 and p53 nuclear factors; Apoptosis of cancer cells; Cancer preventive activity; Starfish; Steroidal glycoside

Indexed keywords

AGAR; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEVIUSCULOSIDE G; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN HL 60; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLOW CYTOMETRY; HENRICIA LEVIUSCULA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; STARFISH; WESTERN BLOTTING;

ASTEROIDEA; HENRICIA LEVIUSCULA;

EID: 70349247228     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800301003     Document Type: Article

References (26)

1. Minale L, Riccio R, Zollo F. (1993) Steroidal oligoglycosides and polyhydroxysteroids from Echinoderms. In Progress in the Chemistry of Organic Natural Products, Vol. 62, Herz W, Kirby GW, Moore RE, Steglich W, Tamm Ch. (Eds). Springer-Verlag, Wien, New York. 75-308.
2. Stonik VA. (2001) Marine polar steroids. Uspekhi Khimii (Russian Chemical Reviews), 70, 673-715.
3. Han C, Qi J, Ojika M. (2006) Structure-activity relationships of novel neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata. Bioorganic & Medicinal Chemistry, 14, 4458-4465. (Pubitemid 43728656)
4. Ivanchina NV, Kicha AA, Kalinovsky AI, Dmitrenok PS, Dmitrenok AS, Chaikina EL, Stonik VA, Gavagnin M, Cimino G. (2006) Polar steroidal compounds from the Far Eastern starfish Henricia leviuscula. Journal of Natural Products, 69, 224-228.
5. Pal'yanova NV, Pankova TM, Starostina MV, Shtark MB, Kicha AA, Ivanchina NV, Stonik VA. (2006) Neurotrophic effects of polyhydroxylated steroids and steroidal glycosides in neuroblastoma culture. Bulletin of Experimental Biology and Medicine, 141, 584-587.
6. Colburn NH, Former BF, Nelson KA, Yuspa SH. (1979) Tumour promoter induces anchorage independence irreversibly. Nature, 281, 589-591.
7. Colburn NH, Wendel EJ, Abruzzo G. (1981) Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proceedings of the National Academy of Sciences USA, 78, 6912-6916.
8. Dong Z, Cmarik JL. (2002) Harvesting cells under anchorage-independent cell transformation conditions for biochemical analyses. Science STKE, PL7.
9. Fedorov SN, Radchenko OS, Shubina LK, Balaneva NN, Bode AM, Stonik VA, Dong Z. (2006) Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascidian Aplidium glabrum, and its synthetic analogs. Pharmaceutical Research, 23, 70-81.
10. 1-S arrest and apoptosis. Cancer Research, 67, 5914-5920.
11. Bernstein LR, Colburn NH. (1989) AP-1/Jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science, 244, 566-569.
12. Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R, Colburn N. (1999) Transgenic mice demonstrate AP-1 (activator protein -1) transactivation is required for tumor promotion. Proceedings of the National Academy of Sciences USA, 96, 9827-9832.
13. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proceedings of the National Academy of Sciences USA, 91, 609-613.
14. Dong Z, Watts SG Sun Y, Colburn NH. (1995) Progressive elevation of AP-1 activity during preneoplastic-to neoplastic progression as modeled in mouse JB6 cell variants. International Journal of Oncology, 7, 359-364.
15. Amit S, Ben-Neriah Y. (2003) NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Seminars in Cancer Biology, 13, 15-28. (Pubitemid 36269177)
16. Beg AA, Baltimore D. (1996) An essential role for NF-κB in preventing TNF-α induced cell death. Science, 274, 782-784.
17. Levine AJ. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
18. Prives C, Hall PA. (1999) The p53 pathway. The Journal of Pathology, 187, 112-126.
19. Vousden KH. (2000) p53: death star. Cell, 103, 691-694.
20. Johnson GL, Lapadat R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298, 1911-1912. (Pubitemid 35425238)
21. Roux PP, Blenis J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews, 68, 320-344.
22. Dubois MA, Higuchi R, Komori T, Sasaki T. (1988) Structures of two new oligoglycoside sulfates, pectinosides E and F, and biological activities of the six new pectinosides. Liebigs Annalen der Chemie, 845-850.
23. Andersson L, Bohlin L, Iorizzi M, Riccio R, Minale L, Moreno-Lopez W. (1989) Biological activity of saponins and saponin-like compounds from starfish and brittle-stars. Toxicon, 27, 179-188. (Pubitemid 19055119)
24. Huang C, Ma WY, Young MR, Colburn N, Dong Z. (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proceedings of the National Academy of Sciences USA, 95, 156-161.
25. Baltrop JA, Owen TC, Cory AH, Cory JG. (1991) 5-(3-Carboxymethoxyphenyl)- 2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorganic & Medicinal Chemistry Letters, 1, 611-614.
26. Bradford MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.